Adam Resnick, PhD
Adam is focused on defining the cell signaling mechanisms of oncogenesis and tumor progression in brain tumors. His lab studies cell signaling cascades and their alterations in pediatric brain tumors to elucidate the molecular and genetic underpinnings of pediatric brain tumors in an effort to identify and develop targeted therapies. Additionally, related studies focus on the characterization of novel cell signaling cascades impinging on cancer biology, including the inositol polyphosphates and their associated metabolism. Adam is director of the Childhood Brain Tumor Tissue Consortium (CBTTC) at the Children's Hospital of Philadelphia, a collaborative multi-institutional cooperative research program dedicated to the study of childhood brain tumors. He received his PhD in Neuroscience from Johns Hopkins School of Medicine.